These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34957387)

  • 1. Integrating COVID-19 health risks into crowding costs for transit schedule planning.
    Devasurendra KW; Saidi S; Wirasinghe SC; Kattan L
    Transp Res Interdiscip Perspect; 2022 Mar; 13():100522. PubMed ID: 34957387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 public transit precautions: Trade-offs between risk reduction and costs.
    Hanig L; Harper CD; Nock D
    Transp Res Interdiscip Perspect; 2023 Mar; 18():100762. PubMed ID: 36743259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On bus ridership and frequency.
    Berrebi SJ; Joshi S; Watkins KE
    Transp Res Part A Policy Pract; 2021 Jun; 148():140-154. PubMed ID: 36569980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 on Public Transit Accessibility and Ridership.
    Wilbur M; Ayman A; Sivagnanam A; Ouyang A; Poon V; Kabir R; Vadali A; Pugliese P; Freudberg D; Laszka A; Dubey A
    Transp Res Rec; 2023 Apr; 2677(4):531-546. PubMed ID: 38602901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will transit recover? A retrospective study of nationwide ridership in the United States during the COVID-19 pandemic.
    Ziedan A; Brakewood C; Watkins K
    J Public Trans; 2023; 25():100046. PubMed ID: 37389199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of COVID-19 on rail passengers' crowding perceptions.
    Aghabayk K; Esmailpour J; Shiwakoti N
    Transp Res Part A Policy Pract; 2021 Dec; 154():186-202. PubMed ID: 34707330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic Optimization of Bus Dispatching Times and Vehicle Schedules Considering the COVID-19 Capacity Limits: A Dutch Case Study.
    Gkiotsalitis K; Liu T
    Transp Res Rec; 2023 Apr; 2677(4):765-777. PubMed ID: 38603130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiple mediation analysis to untangle the impacts of COVID-19 on nationwide bus ridership in the United States.
    Ziedan A; Lima L; Brakewood C
    Transp Res Part A Policy Pract; 2023 Jul; 173():103718. PubMed ID: 37234751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic transit: examining transit use changes and equity implications in Boston, Houston, and Los Angeles.
    Paul J; Taylor BD
    Transportation (Amst); 2022 Oct; ():1-29. PubMed ID: 36340503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the causal relationship between bike-share and public transit in response to the COVID-19 pandemic.
    Kim M; Cho GH
    Cities; 2022 Dec; 131():104024. PubMed ID: 36211221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An estimation of the effects of social distancing measures on transit vehicle capacity and operations.
    Kamga C; Tchamna R; Vicuna P; Mudigonda S; Moghimi B
    Transp Res Interdiscip Perspect; 2021 Jun; 10():100398. PubMed ID: 34514373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive orders or public fear: What caused transit ridership to drop in Chicago during COVID-19?
    Osorio J; Liu Y; Ouyang Y
    Transp Res D Transp Environ; 2022 Apr; 105():103226. PubMed ID: 36570332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using simulation model as a tool for analyzing bus service reliability and implementing improvement strategies.
    Moosavi SMH; Ismail A; Yuen CW
    PLoS One; 2020; 15(5):e0232799. PubMed ID: 32379848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived risks of transit use during COVID-19: Correlates and strategies from a case study in El Paso, Texas.
    Bian JJ; Zhong S; Towne SD; Lee C; Ory MG; Li W
    J Transp Health; 2022 Dec; 27():101491. PubMed ID: 36059855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skip-Stop Strategy Patterns optimization to enhance mass transit operation under physical distancing policy due to COVID-19 pandemic outbreak.
    Limsawasd C; Athigakunagorn N; Khathawatcharakun P; Boonmee A
    Transp Policy (Oxf); 2022 Sep; 126():225-238. PubMed ID: 35880100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of New York City Transit's Bus and Subway Ridership Trends During the COVID-19 Pandemic.
    Halvorsen A; Wood D; Jefferson D; Stasko T; Hui J; Reddy A
    Transp Res Rec; 2023 Apr; 2677(4):51-64. PubMed ID: 37153176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVid-19 influenced households' Interrupted Travel Schedules (COVHITS) survey: Lessons from the fall 2020 cycle.
    Wang K; Liu Y; Mashrur SM; Loa P; Habib KN
    Transp Policy (Oxf); 2021 Oct; 112():43-62. PubMed ID: 34446988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can bring transit ridership back: An econometric study on the potential of usage incentives and operational policies in the Greater Toronto Area.
    Mashrur SM; Wang K; Lavoie B; Habib KN
    Transp Res Part F Traffic Psychol Behav; 2023 May; 95():18-35. PubMed ID: 37035633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 need not spell the death of public transport: Learning from Hanoi's safety measures.
    Nguyen MH; Pojani D
    J Transp Health; 2021 Dec; 23():101279. PubMed ID: 34660200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three's a crowd? Examining evolving public transit crowding standards amidst the COVID-19 pandemic.
    Dai T; Taylor BD
    Public Transp; 2023; 15(2):321-341. PubMed ID: 38625353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.